Eli Lilly will seek regulatory approval for retatrutide, a powerful weight loss drug that a new study shows helped people lose nearly 56 pounds on average.https://t.co/hJFHUvCzeB https://t.co/1V8yOGWqgl ...

Eli Lilly is preparing application materials for its next-generation weight-loss drug, retatrutide, following data from two Phase 3 trials showing the treatment delivered substantial results. https://t.co/vNIKOJl6MZ ...

Eli Lilly plans to seek approval early next year for its next-generation weight-loss shot retatrutide https://t.co/hyOBmg2Wcg ...